# Concentra Group Holdings Parent, Inc.: overview

CON · NYSE · CIK 2014596 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/con.md) · [Financials](/companies/con/financials.md) · [Filings](/companies/con/filings.md) · [Insiders](/companies/con/insiders.md)

Latest reported revenue: [$606.0m](/filings/0002014596-26-000056.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0002014596-26-000056).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [490](/filings/0002014596-25-000046.md) | [465 d](/filings/0002014596-26-000029.md) | [501](/filings/0002014596-26-000044.md) | [551](/filings/0002014596-26-000056.md) | [573](/filings/0002014596-25-000046.md) | [539 d](/filings/0002014596-26-000029.md) | [570](/filings/0002014596-26-000044.md) | [606](/filings/0002014596-26-000056.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [17.6%](/filings/0002014596-25-000046.md) | [12.7% d](/filings/0002014596-26-000029.md) | [16.0%](/filings/0002014596-26-000044.md) | [16.3%](/filings/0002014596-26-000056.md) | [16.5%](/filings/0002014596-25-000046.md) | [12.9% d](/filings/0002014596-26-000029.md) | [16.8%](/filings/0002014596-26-000044.md) | [19.0%](/filings/0002014596-26-000056.md) |
| Net margin | % | [9.1%](/filings/0002014596-25-000046.md) | [4.6% d](/filings/0002014596-26-000029.md) | [7.8%](/filings/0002014596-26-000056.md) | [8.1%](/filings/0002014596-26-000056.md) | [8.4%](/filings/0002014596-25-000046.md) | [6.4% d](/filings/0002014596-26-000029.md) | [8.9%](/filings/0002014596-26-000056.md) | [10.8%](/filings/0002014596-26-000056.md) |
| Diluted EPS | $ per share | [0.37](/filings/0002014596-25-000046.md) | not reported | [0.30](/filings/0002014596-26-000044.md) | [0.35](/filings/0002014596-26-000056.md) | [0.38](/filings/0002014596-25-000046.md) | not reported | [0.39](/filings/0002014596-26-000044.md) | [0.51](/filings/0002014596-26-000056.md) |
| Free cash flow | $m | [50.8 d](/filings/0002014596-25-000046.md) | [77.0 d](/filings/0002014596-26-000029.md) | [(4.0)](/filings/0002014596-26-000044.md) | [63.2 d](/filings/0002014596-26-000056.md) | [39.4 d](/filings/0002014596-25-000046.md) | [98.5 d](/filings/0002014596-26-000029.md) | [9.9](/filings/0002014596-26-000044.md) | [120 d](/filings/0002014596-26-000056.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,724](/filings/0002014596-25-000011.md) | [1,838](/filings/0002014596-26-000029.md) | [1,900](/filings/0002014596-26-000029.md) | [2,163](/filings/0002014596-26-000029.md) |
| Gross margin | % | not reported | not reported | not reported | not reported |
| Operating margin | % | [15.0%](/filings/0002014596-25-000011.md) | [15.6%](/filings/0002014596-26-000029.md) | [16.0%](/filings/0002014596-26-000029.md) | [15.4%](/filings/0002014596-26-000029.md) |
| Net margin | % | [9.7%](/filings/0002014596-25-000011.md) | [9.8%](/filings/0002014596-26-000029.md) | [8.8%](/filings/0002014596-26-000029.md) | [7.7%](/filings/0002014596-26-000029.md) |
| Diluted EPS | $ per share | [1.60](/filings/0002014596-25-000011.md) | [1.73](/filings/0002014596-26-000029.md) | [1.46](/filings/0002014596-26-000029.md) | [1.30](/filings/0002014596-26-000029.md) |
| Free cash flow | $m | [228](/filings/0002014596-25-000011.md) | [169](/filings/0002014596-26-000029.md) | [210](/filings/0002014596-26-000029.md) | [197](/filings/0002014596-26-000029.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/con/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $528.2m | 17,753,714 |  | Added +686,364 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $202.8m | 6,817,456 |  | Added +78,531 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $152.6m | 5,129,815 |  | Added +34,299 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $144.0m | 4,840,099 |  | Added +237,274 |
| [JENNISON ASSOCIATES LLC](/funds/53417.md) | 2026-06-30 | $96.9m | 3,256,435 |  | Added +1,084,144 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $96.0m | 3,225,694 |  | Added +118,440 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $92.2m | 3,099,790 |  | Added +166,616 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $87.0m | 2,922,867 |  | Added +255,673 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $82.9m | 2,780,432 |  | Reduced −239,291 |
| [BARROW HANLEY MEWHINNEY & STRAUSS LLC](/funds/313028.md) | 2026-06-30 | $80.4m | 2,702,531 |  | Reduced −504,773 |

## Recent filings

[All 179 filings](/companies/con/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 16:42 ET | [8-K](/filings/0002014596-26-000064.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002014596-26-000064 |
| 2026-09-01 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-104329.md) | Ownership report, active investor, amended | 0001104659-26-104329 |
| 2026-08-27 | 16:50 ET | [8-K](/filings/0002014596-26-000060.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0002014596-26-000060 |
| 2026-08-24 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-100320.md) | Ownership report, active investor, amended | 0001104659-26-100320 |
| 2026-08-06 | 17:11 ET | [10-Q](/filings/0002014596-26-000056.md) | Quarterly report, period 2026-06-30 | 0002014596-26-000056 |
| 2026-08-06 | 16:49 ET | [8-K](/filings/0002014596-26-000055.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002014596-26-000055 |
| 2026-07-10 | 16:53 ET | [8-K](/filings/0002014596-26-000047.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0002014596-26-000047 |
| 2026-05-07 | 17:03 ET | [10-Q](/filings/0002014596-26-000044.md) | Quarterly report, period 2026-03-31 | 0002014596-26-000044 |
| 2026-05-07 | 16:46 ET | [8-K](/filings/0002014596-26-000042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002014596-26-000042 |
| 2026-04-30 | 16:06 ET | [8-K](/filings/0001104659-26-052886.md) | 5.07 Shareholder vote results | 0001104659-26-052886 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0002014596-26-000029.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a8c60a04-315a-49f9-b177-499511ab8058)

## About the filer

- CIK: 2014596
- Tickers: CON
- Exchange: NYSE
- SIC code: 8093 Services-Specialty Outpatient Facilities, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.